Plante Moran Financial Advisors’s Oramed Pharmaceuticals ORMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Hold |
0
| – | – | – | 877 |
|
|
2023
Q1 | – | Sell |
-7,911
| Closed | -$25.1K | – | 900 |
|
|
2022
Q4 | $95.2K | Hold |
7,911
| – | – | 0.01% | 235 |
|
|
2022
Q3 | $51K | Hold |
7,911
| – | – | 0.01% | 301 |
|
|
2022
Q2 | $36K | Buy |
7,911
+331
| +4% | +$1.77K | 0.01% | 359 |
|
|
2022
Q1 | $66K | Hold |
7,580
| – | – | 0.01% | 288 |
|
|
2021
Q4 | $108K | Hold |
7,580
| – | – | 0.02% | 240 |
|
|
2021
Q3 | $167K | Hold |
7,580
| – | – | 0.04% | 211 |
|
|
2021
Q2 | $101K | Buy |
+7,580
| New | +$86.7K | 0.02% | 247 |
|
|
2017
Q4 | – | Sell |
-300
| Closed | -$3K | – | 907 |
|
|
2017
Q3 | $3K | Hold |
300
| – | – | ﹤0.01% | 704 |
|
|
2017
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 752 |
|
|
2017
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 799 |
|
|
2016
Q4 | $2K | Hold |
300
| – | – | ﹤0.01% | 861 |
|
|
2016
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 845 |
|
|
2016
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 734 |
|
|
2016
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 738 |
|
|
2015
Q4 | $3K | Hold |
300
| – | – | ﹤0.01% | 826 |
|
|
2015
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 663 |
|
|
2015
Q2 | $2K | Hold |
300
| – | – | ﹤0.01% | 683 |
|
|
2015
Q1 | $2K | Hold |
300
| – | – | ﹤0.01% | 673 |
|
|
2014
Q4 | $1K | Hold |
300
| – | – | ﹤0.01% | 787 |
|
|
2014
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 748 |
|
|
2014
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 729 |
|
|
2014
Q1 | $4K | Buy |
+300
| New | +$5.06K | ﹤0.01% | 500 |
|
Other funds holding ORMP
BCM
GCP